ImmunoGen’s stock soared toward a record a record gain Wednesday, after a trial of the biotech’s ovarian cancer treatment produced positive survival data.
You are here: Home / Top Stories / : ImmunoGen stock rockets after ovarian cancer treatment shows ‘meaningful’ survival benefit